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Response to Bayley:
Functional Study Informs
Bioinformatic AnalysisTo the Editor: Computation- or bioinformatic-based pre-
diction of the functional importance of genetic variation
can be a valuable tool in human genetics research. The
most commonly used prediction methods are based
mainly on sequence conservation and/or structural infor-
mation.1 The prediction is often feasible because of the
assumption that the substitutions affecting protein func-
tion tend to happen at evolutionarily conserved sites
and/or reside in critical protein domains. Although bioin-
formatics tools provide helpful information to researchers,
we also need to keep in mind that the interpretation of the
computational results should ideally be consolidated by
molecular evidence from functional studies. This is one
of the recommendations of the MutaDatabase editorial
board. In particular, in cases that lack precise protein
crystal structure data or in special cases in which the
predictive program is less sensitive because of either poorly
or extremely well-conserved sequence across species,
further functional investigation is necessary to rule out
potential false negative or false positive results.2 We
suspect that adding even more biological context, such
as tissue specificity, developmental stage, ethnic back-
ground, etc. will add additional complexity to computa-
tional-based variant prediction.
As is still desirable, all ‘‘first reports’’ should be validated
in an independent series before proceeding to clinical
usage. As such, the original 2008 study3 reporting ten indi-
viduals with PTEN (MIM 601728) mutation-negative
Cowden (MIM 158350) and Cowden-like (MIM 612359)
syndrome who have germline variants in SDHB (MIM
185470) or SDHD (MIM 602690) will need to be indepen-
dently validated in a large series. It should be pointed out
that the genes encoding the succinate dehydrogenase
subunits are highly conserved, such that these genes illus-
trate one of those special situations in which the predic-
tion tools could fail. In our 2008 study, we therefore
showed clear one-to-one correlation between the identi-
fied SDHB or SDHD variants and profound functional
phenotypes such as altered reactive oxygen species and
upregulation of AKT and MAPK (P-ERK1 and P-ERK2).
The latter may explain why SDHB or SDHD variation can
result in similar (but not identical) phenotypes as Cowden
and Cowden-like syndromes: the AKTandMAPK pathways
are important pathways downstream of PTEN as well.4
Finally, we would like to applaud the author of this letter
not only for addressing our specific paper, although we are676 The American Journal of Human Genetics 88, 674–676, May 13,flattered, but also and more importantly for highlighting
the very issues that are and will be germane when whole-
genome sequencing begins to be applied to routine clinical
usage. The author only points out the angst of interpreting
a few variants—albeit even with clear functional data at
hand—but how does one make sense of the enormous
amounts of variation uncovered by whole-genome se-
quencing, especially in the physiological context? Several
efforts have beenmade in creating publicly accessible data-
bases, e.g., MutaDATABASE,5 to improve understanding
and data utilization for clinical practice. In that forum,
the consensus is that functional analysis and physiological
correlations (clinical outcomes) must be performed to
define with certainty the true pathogenic effect of DNA
variations. There is no room for error when patient care
is involved.
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